Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

Management of Metastatic Neuroendocrine Tumor: Should the Primary Lesion be Resected?

411 views
December 14, 2018
Comments 0
Login to view comments. Click here to Login